About Us

About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Binge Eating Disorders Global Market Research Report 2025-2035 | Growth Influenced by Rising Prevalence, Improved Diagnosis, Mental Health Awareness, and Advances in Patient-Centric Treatments - ResearchAndMarkets.com

By: via Business Wire

The "Binge Eating Disorders Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

BED is characterized by recurrent episodes of excessive food consumption accompanied by feelings of loss of control and distress, impacting both psychological and physical health. Notably, advances in screening tools, behavioural therapies, and pharmacological treatments are enabling earlier and more accurate diagnosis, boosting demand for personalized intervention strategies.

However, challenges such as social stigma, limited access to specialized care in low-resource settings, and reimbursement barriers continue to restrict market penetration. Additionally, the heterogeneous nature of BED symptoms and the requirement for integrated, long-term care complicate treatment standardization and scalability. Nevertheless, increasing government initiatives, growing investment in mental health research, and expanded patient support programs are fostering new growth opportunities. Collaborative efforts among healthcare providers, researchers, and advocacy organizations are advancing clinical outcomes and improving quality of life for individuals affected by BED.

Impact

Technological advancements in digital health, teletherapy, and data analytics are significantly improving the diagnosis and management of binge eating disorders (BED). Innovations such as AI-powered screening tools and mobile health applications enable more accurate identification of symptoms and personalized treatment plans. The rise of digital therapeutics and remote counselling platforms is expanding access to behavioural interventions, especially in underserved or remote regions.

Anticonvulsant medications hold the largest market share. This dominance is attributed to robust clinical evidence supporting their efficacy in reducing binge episode frequency and severity. Topiramate has demonstrated significant effectiveness in clinical trials, leading to its widespread adoption in treating moderate to severe BED.

North America holds the highest market share in the binge eating disorders (BED) market, primarily driven by increased awareness, better diagnostic facilities, and higher healthcare expenditure in the region. The U.S. has a well-established healthcare infrastructure and strong government initiatives focused on mental health, facilitating early diagnosis and treatment of BED. Additionally, the presence of major pharmaceutical companies actively investing in research and development for novel BED therapies further consolidates North America's leading position.

How can this report add value to an organization?

Product/Innovation: This report provides comprehensive insights into the current trends in binge eating disorders, helping companies identify opportunities for drug and technology development. Organizations can leverage these insights to design therapies, medications, and platforms tailored to the needs of patients suffering from binge eating disorders, improving outcomes and enhancing market penetration.

Competitive: A detailed competitive landscape analysis helps organizations benchmark their market standing against key players. By understanding the strengths and weaknesses of competitors, companies can position themselves more effectively in the global binge eating disorders market.

Demand Drivers and Limitations

Demand Drivers for the Global Binge Eating Disorders Market:

  • The growing prevalence and diagnosis of binge eating disorder globally and expanding the patient pool. This increased detection fuels demand for effective treatments.
  • Enhanced mental health awareness and reduced stigma encourage more individuals to seek professional help. Greater acceptance supports higher treatment adoption rates.
  • Advancements in treatment options and patient centric care models improve outcomes. Personalized approaches are attracting more patients to engage in care.

Limitations for the Global Binge Eating Disorders Market:

  • Underdiagnosis remains a significant issue due to social stigma and limited public awareness. This results in many patients not receiving timely or appropriate treatment.
  • The high cost of innovative therapies restricts access for a large portion of the patient population. Affordability remains a barrier, especially in lower-income regions.
  • Regulatory hurdles contribute to prolonged approval timelines for new drugs. These delays slow down the availability of advanced treatment options in the market.

Key Market Players and Competition Synopsis

The companies profiled in this report have been selected based on their market presence, product portfolio, and competitive positioning in the global binge eating disorders market

  • Eli Lilly and Company
  • Amneal Pharmaceuticals, Inc.
  • Takeda Pharmaceutical, Ltd.
  • Tryp Therapeutics Inc.
  • Tonix Pharmaceuticals Corp.
  • Sumitomo Pharma Ltd.
  • VIVUS Inc
  • Novartis AG
  • Pfizer Inc.

Key Topics Covered:

1. Global Binge Eating Disorders Market: Industry Analysis

1.1 Market Overview and Ecosystem

1.2 Epidemiological Analysis

1.3 Key Market Trends

1.3.1 Impact Analysis

1.4 Regulatory Landscape

1.5 Pipeline Analysis

1.6 Market Dynamics

1.6.1 Overview

1.6.2 Market Drivers

1.6.3 Market Restraints

1.6.4 Market Opportunities

2. Global Binge Eating Disorders Market (by Drug Class), Value ($million), 2023-2035

2.1 Antidepressant

2.2 Anticonvulsant

2.3 Anti-obesity

2.4 Others

3. Global Binge Eating Disorders Market (by Region), Value ($Million), 2023-2035

3.1 North America

3.1.1 Market Dynamics

3.1.2 Market Sizing and Forecast

3.1.3 North America Binge Eating Disorders Market, by Country ($Million), 2023-2035

3.1.3.1 U.S.

3.1.3.2 Canada

3.2 Europe

3.2.1 Market Dynamics

3.2.2 Market Sizing and Forecast

3.2.3 Europe Binge Eating Disorders Market, by Country ($Million), 2023-2035

3.2.3.1 U.K.

3.2.3.2 France

3.2.3.3 Germany

3.2.3.4 Italy

3.2.3.5 Spain

3.2.3.6 Rest-of-Europe

3.3 Asia-Pacific

3.3.1 Market Dynamics

3.3.2 Market Sizing and Forecast

3.3.3 Asia-Pacific Binge Eating Disorders Market, by Country ($Million), 2023-2035

3.3.3.1 Japan

3.3.3.2 China

3.3.3.3 India

3.3.3.4 Australia

3.3.3.5 South Korea

3.3.3.6 Rest-of-Asia-Pacific

3.4 Rest-of-the-World

3.4.1 Market Dynamics

3.4.2 Market Sizing and Forecast Rest-of-the-World Binge Eating Disorders Market, by Type ($Million), 2023-2035

3.4.3 Rest-of-the-World Binge Eating Disorders Market, by Country ($Million), 2023-2035

3.4.3.1 Latin America

3.4.3.2 Middle East and Africa

4. Competitive Landscape and Company Profiles

4.1 Competitive Landscape

4.1.1 Mergers and Acquisitions

4.1.2 Partnership, Alliances and Business Expansion

4.1.3 New Offerings

4.1.4 Regulatory Activities

4.1.5 Funding Activities

4.2 Company Profiles

4.2.1 Eli Lilly and Company

4.2.1.1 Overview

4.2.1.2 Top Products / Product Portfolio

4.2.1.3 Top Competitors

4.2.1.4 Target Customers/End-Users

4.2.1.5 Key Personnel

4.2.1.6 Analyst View

4.2.2 Amneal Pharmaceuticals, Inc.

4.2.3 Takeda Pharmaceutical, Ltd.

4.2.4 Tryp Therapeutics Inc

4.2.5 Tonix Pharmaceuticals Corp.

4.2.6 Sumitomo Pharma Ltd.

4.2.7 VIVUS Inc

4.2.8 Novartis AG

4.2.9 Pfizer Inc.

5. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/rrk8fm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

More News

View More
Cybersecurity Market Set to Double: This ETF Offers Exposure
Via MarketBeat
Topics Artificial Intelligence Credit Cards ETFs
Tickers BUG CRWD CYBR PANW VRNS ZS
Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
Via MarketBeat
Topics Artificial Intelligence
Tickers CRM CRWD FTNT
Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
Via MarketBeat
Topics ETFs
Tickers DFDV F FORD JNVR MSTR UPXI
Ford Set to Outpace GM With Tariff Tailwinds and EPS Momentum
Via MarketBeat
Topics World Trade
Tickers F GM TSLA
Replace Your Fixed Income With This Dividend ETF
Via MarketBeat
Topics ETFs Economy
Tickers AMZN JEPI META NVDA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.